NEWS
TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering
TC BioPharm (NASDAQ: TCBP) has successfully closed its upsized $6.0 million public offering. The offering included 6,000,000 American Depository Shares (ADSs) or pre-funded warrants, along with Series H warrants to purchase up to 6,000,000 ADSs at a combined price of $1 per ADS. The Series H Warrants have an exercise price of £0.76 per ADS and will expire in one year. Each ADS represents 200 ordinary shares of the company.
The net proceeds will be used to support TC BioPharm's upcoming clinical trial on relapse/refractory Acute Myeloid Leukemia, increase market awareness, and cover operating expenses and working capital. This offering was made through a registration statement on Form F-1 declared effective by the SEC on August 28, 2024.
The net proceeds will be used to support TC BioPharm's upcoming clinical trial on relapse/refractory Acute Myeloid Leukemia, increase market awareness, and cover operating expenses and working capital. This offering was made through a registration statement on Form F-1 declared effective by the SEC on August 28, 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1690Followers
93Following
13KVisitors
Follow
HugoV : Is that good or bad?
Jaguar8 OP HugoV : The dilution is finished so it’s good
B_jammin Jaguar8 OP : isn't this new new F-1MEF adding an extra 2million shares?
Jaguar8 OP B_jammin : I haven’t read it yet. I’ll do it later. Just doing something. I only day traded this awhile ago.
Jaguar8 OP B_jammin : Yes I read it. Additional 2M shares
B_jammin Jaguar8 OP : Trying to increase liquidity with the patent news maybe?
Jaguar8 OP B_jammin : It needs more capital for its ongoing projects.
B_jammin : makes sense. thanks.